Correction: Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinoma.
0/5 보강
APA
Cao W, Yang K, et al. (2025). Correction: Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinoma.. Journal of nanobiotechnology, 23(1), 642. https://doi.org/10.1186/s12951-025-03699-y
MLA
Cao W, et al.. "Correction: Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinoma.." Journal of nanobiotechnology, vol. 23, no. 1, 2025, pp. 642.
PMID
41074157 ↗
같은 제1저자의 인용 많은 논문 (5)
- Hypoxia-induced exosomal circ_0006840 promotes pancreatic cancer progress by regulating the WIF1 decay.
- Combining network pharmacology and transcriptomics to validate and explore Shenqiyichang decoction in treating colorectal cancer by NQO1 inhibition, ROS activation and Wnt/β-catenin signaling pathway.
- Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinoma.
- Effect and mechanism of the miR-1284/EIF4A1 axis on the cGAS-STING pathway under radiotherapy.
- Postoperative early recurrence prediction of pancreatic cancer based on CT and pathomics.